Medication info
Esol Tablet 40 mg (Olmesartan Medoxomil)

Esol Tablet 40 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201101844 · Approved 2011.03.31 · Insurance code 644003160

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily and may be taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients aged 65 years and older. No overall differences in efficacy and safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Used to control blood pressure within a normal range for essential hypertension, reducing the risk of cardiovascular diseases.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily and may be taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients aged 65 years and older. No overall differences in efficacy and safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus or newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this drug, pregnant women, breastfeeding women, patients undergoing renal dialysis, patients with severe liver dysfunction, and patients with biliary obstruction should not use this drug. Additionally, patients with hereditary metabolic disorders such as lactose intolerance should not take this medication. When administering this drug for the treatment of hypertension, caution is needed as patients with low blood volume or salt may experience hypotension, and appropriate measures should be taken immediately if symptoms occur. Patients with impaired kidney function or who have received kidney transplants should regularly monitor and manage potassium and creatinine levels in the blood. As this drug has an effect of lowering blood pressure, dizziness may occur; therefore, it is advisable to avoid hazardous activities such as working at heights or driving. This drug can cause hyperkalemia, so particularly patients with heart failure or reduced kidney function should frequently check serum potassium levels. If gastrointestinal disorders such as chronic diarrhea occur, the use of this drug should be discontinued and a physician consulted, and symptoms of intestinal vascular swelling should also be closely monitored. The blood pressure-lowering effect may be increased when this drug is taken with other antihypertensives, and the co-administration of potassium-sparing diuretics or potassium supplements can dangerously elevate serum potassium levels. Lithium preparations should not be taken together, as co-administration may lead to elevated lithium levels and toxicity. When taken with non-steroidal anti-inflammatory drugs, there is a risk of deteriorating renal function, so kidney function should be monitored regularly. Taking this drug during pregnancy can lead to serious problems such as decreased kidney function in the fetus, oligohydramnios, and cranial developmental delays, so it should be discontinued immediately upon learning of pregnancy. Breastfeeding women should consider that this drug may be passed into breast milk, so they should discontinue breastfeeding or the medication to prevent adverse reactions in the baby. The safety and efficacy in children have not been sufficiently established, so it is generally not administered to children. In case of overdose, hypotension and palpitations may occur, and appropriate emergency treatment should be obtained if necessary.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 41 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • indigestion
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • increased blood creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • positional vertigo
  • palpitations
  • increased blood pressure
  • elevated blood creatinine
  • epistaxis
  • upper respiratory tract infection
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and light. It is important to maintain a storage temperature between 1 and 25 degrees Celsius, as this helps to preserve the drug's efficacy and safety over time.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.